ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ZIMMER BIOMET HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$94.99+0.01 (+0.01%)
Close on Oct 19, 2026
- Market cap
- $18.31B
- P/E (TTM)
- 23.1
- Dividend yield
- 1.01%
Share price
−$6.93 (−6.80%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
ZIMMER BIOMET HOLDINGS, INC. grew revenue 8.6% to $8.51B over the twelve months to Jun 30, 2026. Operating income fell 4.4% to $1.21B, moving the operating margin from 16.1% to 14.2%. Free cash flow was $1.52B, up 3.4% from a year earlier.
Revenue
$8.51B
+8.6% vs. a year earlier
Operating income
$1.21B
-4.4% vs. a year earlier
Free cash flow
$1.52B
+3.4% vs. a year earlier
EPS, diluted
$4.11
0.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $18.31B
- P/E ratio
- 23.1
- Price to sales
- 2.15
- Price to book
- 1.45
- Dividend yield
- 1.01%
- Free cash flow yield
- 8.32%
Fundamentals
- Revenue
- $8.51B
- Net income
- $806.60M
- EPS, diluted
- $4.11
- Free cash flow
- $1.52B
- Book value per share
- $65.48
- Diluted shares
- 193M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$8.51B+8.6% YoY
Gross profit
$5.95B+6.8% YoY
Operating income
$1.21B-4.4% YoY
Net income
$806.60M-2.0% YoY
EPS, diluted
$4.110.0% YoY
Free cash flow
$1.52B+3.4% YoY
Reported periodTrailing twelve months